亚太药业(002370.SZ)：实际控制人拟变更为邱中勋 股票复牌

Core Viewpoint - Asia-Pacific Pharmaceutical (002370.SZ) announced a share transfer agreement involving its controlling shareholder, Fubon Group, and its associates, transferring 14.62% of the company's shares to Zhejiang Xinghao Holdings and Zhejiang Xingchen Investment [1] Group 1: Share Transfer Details - Fubon Group and Han Gui Investment plan to transfer a total of 108,945,566 shares at a price of 8.26 yuan per share, amounting to a total of 900 million yuan [1] - Xinghao Holdings will acquire 60,525,314 shares from Fubon Group, while Xingchen Investment will acquire 28,894,686 shares and 19,525,566 shares from Fubon Group and Han Gui Investment, respectively [1] Group 2: Changes in Control - Following the completion of the share transfer, the controlling shareholder will change from Fubon Group to Xinghao Holdings [1] - The actual controller will shift from a management team consisting of Song Hanping, Fu Cai, and Hu Zhenghui to Qiu Zhongxun [1] Group 3: Stock Resumption - The company's stock (trading name: Asia-Pacific Pharmaceutical, stock code: 002370) will resume trading on October 14, 2025 [1]